Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 26, 2001

View Archived Issues

MorphoSys Sells 10% Stake As Part Of Schering Collaboration

Parasites Yield Clues That Could Lead To Therapeutic Approaches

CAT Expands Pipeline Through Alliances With Incyte, Amrad

Gyros Raises $30M To Fund Microlab Production Plant

Mindset Gets $15M Commitment To Help Fund CNS Programs

GroPep Gains Manufacturing Capability Through Purchase

Biota Wants To Improve Pipeline, Business; CEO Stepping Down

Pharmacore Raises $4.5M To Fund Development Programs

Merck Takes Celltech Compound Forward; Separate Drug Sidelined

Other News To Note

Recombinant Factor VIIa Used Successfully In Trauma Setting

Largest UK Cancer Charities Merging Into One Organization

Xantos Raises EUR21M To Fund Functional Genomics, Screening

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.